DIVI S LABORATORIES LTD vs DR. LAL PATH LABS LTD.

A side-by-side comparison of DIVI S LABORATORIES LTD (DIVISLAB) and DR. LAL PATH LABS LTD. (LALPATHLAB) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

On the numbers, DIVI S LABORATORIES LTD leads DIVISLAB vs LALPATHLAB on 8 of 14 metrics. See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).

Valuation

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

74.93
P/E ratio
56.00
10.72
P/B ratio
11.26
0.44%
Dividend yield
1.22%
₹96.73
EPS
₹30.13

Profitability

How efficiently each company turns capital and sales into profit. Higher is better.

16.50%
Return on equity
22.50%
22.00%
Return on capital
28.00%
33.00%
EBITDA margin
28.00%
24.32%
Net margin
18.46%

Growth

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

10.78%
Revenue CAGR (3Y)
11.06%
12.10%
Profit CAGR (3Y)
28.39%

Size & financial health

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹1.92L Cr
Market cap
₹28,262 Cr
₹10,560 Cr
Revenue
₹2,763 Cr
₹2,568 Cr
Net profit
₹510 Cr
0.00
Debt / equity
0.08
DIVI S LABORATORIES LTD
  • + ["Company is almost debt free.", "Company has been maintaining a healthy dividend payout of 39.0%"]
  • ["Stock is trading at 10.8 times its book value", "The company has delivered a poor sales growth of 8.67% over past five years."]
DR. LAL PATH LABS LTD.
  • + ["Company is almost debt free.", "Company has been maintaining a healthy dividend payout of 36.4%"]
  • ["Stock is trading at 11.3 times its book value", "The company has delivered a poor sales growth of 11.8% over past five years."]
DIVI S LABORATORIES LTD full analysis DR. LAL PATH LABS LTD. full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.